BUY Jubilant Ingrevia Limited — Anand Rathi

Entry₹632.35Inferred
Target₹900
Total upside +42.33%
Stop lossNot given
CMP₹593.68h ago
Active-6.13%+51.62%upside left 12 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 12:47 am IST
10 supporting4 neutral1 opposing
Supports the BUY call (10)

Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth

NewsCnbc-Tv18·27 Oct · yesterday

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·24 Sept · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.